HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Sugiyama Selected Research

Acatalasia (Acatalasemia)

12/2011Development of angiotensin II-induced abdominal aortic aneurysms is independent of catalase in mice.
2/2010Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice.
1/2008Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice.
9/2005Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.
6/2004Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Sugiyama Research Topics

Disease

21Proteinuria
02/2022 - 04/2002
19Glomerulonephritis
10/2022 - 11/2003
15IGA Glomerulonephritis (IGA Nephropathy)
01/2022 - 11/2003
14Fibrosis (Cirrhosis)
05/2021 - 02/2001
11Diabetic Nephropathies (Diabetic Nephropathy)
12/2018 - 07/2004
9Albuminuria
01/2022 - 07/2004
9Chronic Renal Insufficiency
11/2021 - 01/2011
8Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 01/2002
7Chronic Kidney Failure (Chronic Renal Failure)
09/2022 - 05/2006
7Fabry Disease (Fabry's Disease)
06/2021 - 02/2008
7Hypertrophy
01/2015 - 07/2002
6Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022 - 01/2002
6Acute Kidney Injury (Acute Renal Failure)
12/2021 - 01/2006
6Interstitial Nephritis (Tubulointerstitial Nephritis)
12/2021 - 01/2017
6Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
07/2019 - 08/2012
5Atrophy
05/2021 - 06/2004
5Inflammation (Inflammations)
01/2021 - 09/2004
5Neoplasms (Cancer)
05/2020 - 08/2012
5Nephritis
10/2016 - 09/2004
5Acatalasia (Acatalasemia)
12/2011 - 06/2004
4Lupus Nephritis
02/2022 - 07/2003
4Infections
02/2022 - 09/2008
4Hematuria
02/2022 - 10/2019
4Hypertension (High Blood Pressure)
01/2022 - 07/2006
4Obesity
01/2022 - 06/2012
4Kidney Diseases (Kidney Disease)
10/2019 - 01/2012
4Vasculitis (Vasculitides)
01/2017 - 10/2013
4Hyperglycemia
01/2015 - 10/2005
4Body Weight (Weight, Body)
01/2012 - 12/2005
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2022 - 08/2006
3Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022 - 04/2002
3Type 2 Diabetes Mellitus (MODY)
11/2021 - 05/2006
3Frailty
12/2018 - 04/2018
3Wounds and Injuries (Trauma)
06/2012 - 07/2006
2Hearing Loss (Hearing Impairment)
03/2022 - 01/2006
2Diabetes Mellitus
01/2022 - 01/2017
2Hemolytic Anemia
04/2021 - 10/2011
2Hemolysis
04/2021 - 08/2006
2Membranous Glomerulonephritis (Membranous Nephropathy)
10/2020 - 12/2008
2Anemia
01/2020 - 01/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2019 - 01/2018
2Microscopic Polyangiitis
07/2019 - 01/2017
2Disease Progression
01/2016 - 01/2014
2Posterior Leukoencephalopathy Syndrome
11/2015 - 11/2012
2Peritoneal Fibrosis
02/2014 - 01/2008
2Collagen Diseases (Collagen Disease)
08/2012 - 12/2008

Drug/Important Bio-Agent (IBA)

14CreatinineIBA
09/2022 - 08/2005
11Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
11Immunoglobulin A (IgA)IBA
01/2022 - 11/2003
11Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 08/2012
9Pharmaceutical PreparationsIBA
10/2022 - 08/2012
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 07/2004
7Antigen-Antibody Complex (Immune Complex)IBA
01/2021 - 11/2003
7Proteins (Proteins, Gene)FDA Link
06/2015 - 07/2002
7Angiotensin IIIBA
12/2011 - 02/2001
6Collagen Type IV (Type IV Collagen)IBA
01/2015 - 06/2004
5SteroidsIBA
01/2022 - 06/2005
5Prednisolone (Predate)FDA LinkGeneric
08/2019 - 08/2009
5CatalaseIBA
03/2012 - 06/2004
4LectinsIBA
01/2022 - 01/2007
4Serum AlbuminIBA
01/2022 - 01/2017
4globotriaosyl lysosphingolipidIBA
08/2019 - 01/2019
4Angiogenesis InhibitorsIBA
01/2018 - 07/2004
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 08/2009
3Glucose (Dextrose)FDA LinkGeneric
11/2021 - 05/2010
3GlucocorticoidsIBA
04/2021 - 04/2002
3Galactose (Galactopyranose)FDA LinkGeneric
01/2021 - 01/2016
3AlbuminsIBA
01/2019 - 01/2012
3Cisplatin (Platino)FDA LinkGeneric
01/2019 - 01/2008
3EnzymesIBA
01/2019 - 09/2005
3Streptozocin (Streptozotocin)FDA Link
01/2018 - 07/2004
3Hemoglobins (Hemoglobin)IBA
10/2017 - 08/2006
3Therapeutic UsesIBA
01/2015 - 04/2011
3AdiponectinIBA
01/2012 - 08/2006
3CytokinesIBA
01/2012 - 11/2003
3C-Reactive ProteinIBA
11/2010 - 12/2006
3Angiopoietin-1IBA
01/2007 - 08/2005
2anti-dsDNA autoantibodyIBA
02/2022 - 07/2003
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2022 - 11/2015
2Polysaccharides (Glycans)IBA
01/2022 - 01/2021
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2021 - 11/2015
2GalactosidasesIBA
06/2021 - 01/2019
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2020 - 11/2003
2Immune Checkpoint InhibitorsIBA
05/2020 - 01/2020
2SodiumIBA
01/2020 - 01/2019
2Cystatin CIBA
01/2020 - 01/2018
2MethylprednisoloneFDA LinkGeneric
10/2019 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 11/2003
2Blood Glucose (Blood Sugar)IBA
10/2017 - 05/2006
2Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2015 - 06/2012
2ONO 1301IBA
01/2015 - 06/2012
2AntibodiesIBA
06/2012 - 08/2005
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2012 - 12/2006

Therapy/Procedure

20Therapeutics
02/2022 - 04/2002
5Renal Dialysis (Hemodialysis)
04/2021 - 01/2006
4Tonsillectomy
10/2019 - 06/2005
4Intraperitoneal Injections
01/2018 - 12/2005
4Peritoneal Dialysis
11/2012 - 01/2008
2Kidney Transplantation
12/2020 - 08/2011
2Remission Induction
07/2019 - 01/2017